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ABSTRACT
The integron platform codes for an integrase (IntI)
from the tyrosine family of recombinases that
mediates recombination between a proximal
double-strand recombination site, attI and a
single-strand target recombination site, attC. The
attI site is only recognized by its cognate integrase,
while the various tested attCs sites are recombined
by several different IntI integrases. We have devel-
oped a genetic system to enrich and select mutants
of IntI1 that provide a higher yield of recombination
in order to identify key protein structural elements
important for attC attI1 recombination. We iso-
lated mutants with higher activity on wild type and
mutant attC sites. Interestingly, three out of four
characterized IntI1 mutants selected on different
substrates are mutants of the conserved aspartic
acid in position 161. The IntI1 model we made based
on the VchIntIA 3D structure suggests that substitu-
tion at this position, which plays a central role in
multimer assembly, can increase or decrease the
stability of the complex and accordingly influence
the rate of attI attC recombination versus
attC attC. These results suggest that there is a
balance between the specificity of the protein and
the protein/protein interactions in the recombina-
tion synapse.
INTRODUCTION
Integrons are the primary system for antibiotic-resistance
gene capture and dissemination among Gram-negative
bacteria. They are natural cloning and expression devices
that incorporate open reading frames (ORF) and convert
them to functional genes (1). The integron platform codes
for an integrase (IntI) that catalyses site-speciﬁc
recombination between a proximal primary recombina-
tion site, attI and a secondary target, called an attC site.
The attC site is normally found associated with a
promoterless single ORF, and the ORF-attC structure is
termed a gene cassette. Upon recombination between attI
and attC, the gene gains a promoter and is expressed.
IntI belongs to the family of tyrosine recombinases
(Y-recombinases), of which phage  integrase (Int)i s
the paradigm. Their C-terminal catalytic domain contains
the conserved amino acids Arg146–Lys171–His277–Arg280–
His/Trp303 and the nucleophilic tyrosine, Tyr312 (IntI1
nomenclature). However, an additional insertion of ca.
25 amino acids, carrying an additional a-helix [I2 in (2)],
conserved within the IntI (3–5) is also present.
The site-speciﬁc recombination mechanism involves
a tetramer of proteins of which only two subunits are
active per cleavage round. Their catalytic tyrosine forms
a reversible protein-DNA intermediate that is either
resolved back to substrate when the free 50-hydroxyl
attacks in cis, or if its the invading DNA strand,
a Holliday junction (HJ) is formed. For most of the
Y-recombinases, the locus of these reactions is a simple
site composed of a pair of 9- to 13-bp inverted binding
sites, separated by a 6- to 8-bp overlap region.
The integron recombination sites, attI and attC, do not
preserve this structure. The attC sites are composed of two
simple sites at the boundaries of an imperfect palindromic
region, whilst the attI can vary in sequence and is devoid
of a palindromic sequence. We have demonstrated that
IntI1 recombines the single bottom strand of the attC sites
(bs attC), folded in an imperfect hairpin structure with
extrahelical bases, and the double-stranded (ds) attI1
substrate (2,6). Cassette insertion at the attI1 by IntI1
results in a HJ intermediate. However, because of the
single-stranded (ss) structure of the attC site, the
HJ cannot be resolved by a second-strand exchange,
which would result in a linearization of the replicon
carrying the integron. We have proposed that a replication
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initial attI site and integrates the gene cassette (6).
The 3D structure of the Vibrio cholerae integron
integrase, VchIntIA, in complex with a bs attC DNA
substrate (2) showed some dissimilarity with Cre. Several
secondary structural elements have evolved to provide
essential interactions (2) between particular amino acids
and the folded bs attC extrahelical bases.
IntIs are strictly speciﬁc for their cognate attI sites but
are able to recombine attC sites of very diﬀerent sequences
and structures with comparable eﬃciency, as illustrated
by VchIntIA (7), IntI2
 179E (8)) and IntI3 (9). IntI1
eﬃciently recombines attC sites with the attI1 site but not
with the attIVch (7), attI2 (8) or attI3 (9) sites. Several
studies show that IntI1 (7,10–12), IntI2 (8) and VchIntIA
(7) are all able to recombine various attC sites. This is still
puzzling, as in vivo and in vitro data do not completely
overlap. Indeed, while IntI1 is able to recombine single-
strand DNA folded in an imperfect hairpin structure and
double-strand DNA with high eﬃciency in vivo, its in vitro
aﬃnity toward ds attI1 is low compared to its aﬃnity for
bs attC (6,13).
The tolerance of IntI for attC sites is remarkable
compared to other Y-recombinases. Structural analysis of
the VchIntIA complex suggests that the tolerance relies
in part on recognition of the extrahelical bases, which
directs binding to the bs attC site and high order complex
assembly (2). However, the crystal structure does not give
a dynamic view of the recombination reaction and
structural data for attI site recognition are still very
loose (14,15). Here, we present a study performed with the
aim of identifying key structural elements in IntI, more
speciﬁcally in the IntI1 paradigm, involved in the
attC attI recombination reaction eﬃciency.
We chose to study the IntI speciﬁcity and eﬃciency in
the context of the attC attI integrative reaction, by
mutagenesis of the integrase and selection of the mutants
showing a higher recombination activity, a strategy
successfully used to study the ﬂipase (FLP) speciﬁcity
on its FRT sites (16). Hence, we performed an extensive
mutagenesis of intI1 by mutagenic PCR and generated a
10
5 independent clone library, with the aim of selecting for
the more active mutants. In order to facilitate the
structural analyses, we choose to perform all selections
using the attC site from the V. cholerae superintegron
cassettes, named VCR (for V. cholerae repeats), or its
mutated derivatives, as the structural data previously
obtained corresponded to complexes of VchIntIA with
this speciﬁc attC site. We realized three independent
enrichment assays. The ﬁrst was made using a wild-type
VCR. The other two assays were done with two diﬀerent
VCR mutants, VCRINV and VCRGTT. VCRINV is a VCR
derivative in which the unpaired central spacer sequences
are inverted, since structural data suggested that this
region could direct the bending of the bs attC tertiary
structure, and as such play an important role for
recombination. In VCRGTT, the three extrahelical bases,
G, T and T [G2000, T1600 and T1200 respectively, (2)], which
are speciﬁcally recognized by the integrase, are comple-
mented. IntI1 and VchIntIA show 65% similarity and in
order to interpret the diﬀerent properties shown by these
mutants, we further modeled the IntI1 3D structure based
on the VchIntA crystal structure (2).
MATERIALS AND METHODS
Bacterial strains, plasmids and media
Bacterial strains and plasmids are described in Tables 1
and 2. Escherichia coli strains were grown in Luria
Bertani broth (LB) at 378C. Antibiotics were used at the
following concentrations: ampicillin (Ap), 100mg/ml,
chloramphenicol (Cm), 25mg/ml, kanamycin (Km),
25mg/ml. Diaminopimelic acid (DAP) was supplemented
when necessary to a ﬁnal concentration of 0.3mM.
IPTG (isopropyl-beta- D-thiogalactopyranoside) and
L-arabinose were added at, respectively, 0.8mM and
2mg/ml ﬁnal concentration. Chemicals were obtained
from Sigma-Aldrich (France).
Polymerase chain reaction (PCR) procedures
PCR for plasmid assembly used the Pfu DNA polymerase
(Promega). For PCR reactions followed by topo cloning
GoTaq polymerase (Promega) was used. Other PCR
reactions used the PCR Reddy mix (Abgene, UK). All
were used according to the manufacturer’s instructions.
PCR primers listed in Table 3 were obtained from Proligo
(France).
Construction of pSU38::lacZ::attCaadA7-catT4-VCR2
Each independent element (attCaadA7, catT4 and VCR2)
was assembled in pUC19 (Table 2). The primers aada7-3
and aada7-4 (Table 3) were phosphorylated by T4
polynucleotide kinase, annealed and cloned in pUC19
digested by EcoRI and BamHI. The catT4 gene was
ampliﬁed using primers cat-del-1 and cat-del-2 (Table 3)
from pSU18 (17), digested by BamHI and BglII and
cloned in pUC19::attCaadA7 digested by the same enzymes.
Finally, the synthetic cassette was assembled by cloning
Table 1. Bacterial strains used in this study
E.coli strains Description/Relevant
characteristics
Reference
DH5a (F
 ) supE44 DlacU169
(F80lacZDM15)DargF
hsdR17 recA1 endA1 gyrA96
thi-1 relA1
Laboratory
collection
TG1 (F
 )( F
 ) supE hsdD5 thi
D(lac-proAB)
Laboratory
collection
b2163 (F
 ) RP4-2-Tc::Mu DdapA
::(erm-pir) [Km
R Em
R]
(29)
KS272 F
  lacX74, galE, galK, thi
rpsL (StrA) phoA (PvuII)
Ghigo J.M.
unpublished
data
B462 DH2 lacIQ, thi1, relA1, supE44,
endA1, recA1, hsdR17,
gyrA462, zei298::Tn10
(20)
BL21(DE3)pLysS E.coli B strain containing the T7
polymerase and plasmid
pLysS expressing T7 lysozyme
(30)
o198 B462 (pSU38ccdB-attI1) This study
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VCR2 (7) in the pUC19::attCaadA7-catT4, digested by the
same enzymes, leading to the p1187 (pUC19::attCaadA7-
catT4-VCR2).
The lacZa gene of pSU38 was replaced by the entire
lacZ gene. First, lacZa was deleted by inverse PCR.
pSU38 was ampliﬁed with primers PSDMF and PSDH3
(Table 3), digested by MfeI and religated, leading to
p1266. lacZ was ampliﬁed from pRS551 [Table 2, (18)],
with primers LZFT-1 and LZFT-2 (Table 3), digested by
EcoRI and HindIII and cloned in p1266, digested with the
same enzymes, leading to p1370 (Table 2).
Finally, the EcoRI/SphI fragment from p1187, contain-
ing the synthetic cassette, was cloned in p1370 digested by
EcoRI and SphI, generating pSU38i::lacZ::attCaadA7-
catT4-VCR2 (p1372).
Construction ofpETHis-intI1, pETHis-intI1P109L and
pETHis-intI1D161G
The IntI1 genes from plasmid p734, p4067 and p4130
(Table 2), were ampliﬁed with GoTaq polymerase
(Promega) using primers HisIntI1 (Table 3) which
contains a NdeI site and a tag coding for 10 histidines
downstream of the ATG start codon of the intI1 gene,
and BamH1Int-rev (Table 3). The diﬀerent amplicons
were cloned into pTopo 2.1 (Invitrogen). Correct clones
were selected after sequencing, and the various intI
genes were transferred into vector pET3a using the NdeI
and BamHI unique sites.
Table 3. Oligonucleotides
Oligonucleotides Sequences
EMSA experiments
VCRWT GGATCCGGTTATAACGCCCGCCTAAGGGGCTGACAACGCGAAGCGTTGAC
AGTCCCTCTTGAGGCGTTTGTTATAACAGATCTGAATTC
VCRDG GGATCCGGTTATAACGCCCGCCTAAGGGGCTGACAACGCGAAGCGTTGAC
AGTCCCTCTTAGGCGTTTGTTATAACAGATCTGAATTC
VCRG GGATCCGGTTATAACGCCCGCCTCAAGGGGCTGACAACGCGAAGCGTTGA
CAGTCCCTCTTGAGGCGTTTGTTATAACAGATCTGAATTC
VCRDGTT GGATCCGGTTATAACGCCCGCCTAAGGGGCTGACAACGCGAAGCGTTGAC
AGCCCCTTAGGCGTTTGTTATAACAGATCTGAATTC
VCRGTT GGATCCGGTTATAACGCCCGCCTCAAGAGGGACTGACAACGCGAAGCGTTGAC
AGTCCCTCTTGAGGCGTTTGTTATAACAGATCTGAATTC
VCRCOMP GGATCCGGTTATAACAAACGCCTAAGGGGCTGACAACGCGAAGCGTTGAC
AGTCCCTCTTGAGGCGTTTGTTATAACAGATCTGAATTC
VCRINV GGATCCGGTTATAACTTTCGCCTAAGGGGCTGACAACGCGAAGCGTTGAC
AGTCCCTCTTGAGGCGGCCGTTATAACAGATCTGAATTC
Plasmids construction
aada7-3 AATTCGGTTATAACAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCTT
AATTCAAGCGTTAGATGG
aada7-4 GATCCCATCTAACGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCGGCTT
GAATGAATTGTTATAACCG
cat-del-1 CGCGGATCCACTGCCTTAAAAAAATTACGCCCCGCCCTGCC
cat-del-2 GGAAGATCTAAAAAAAAGCCCGCTCATTAGGCGGGCTCGAATAAATACCT
GTGACGG
PSDMF GGCTCAATTGGCATGCCTGCAGGTCGACTCTA
PSDH3 GGCTCAATTGAAGCTTGTCCGGCGGTGCTTTTGCCGTTA
LZFT-1 GTGAATTCCCGCGCACTGGCCGTCGTTTTACAACG
LZFT-2 GCGGATCCAAGCTTACCGAACATCCAAAAGTTTGTGT
HisIntI1 GCCATATGCATCATCATCATCATCATCATCATCATCATAAAACCGCCACTG
CGCCG
BamH1Int-rev GCGGATCCCTACCTCTCACTAGTGAGGGG
Reverse AGCGGATAACAATTTCACACAGGA
Forward CGCCAGGGTTTTCCCAGTCAC
Table 2. Plasmids used in this study
Plasmids Description Reference
pUC19 oriColE1 [Ap]
R (31)
pSU18 orip15A [Cm]
R (17)
pSU38 orip15A [Km]
R (17)
pRS551 oriColE1 [Ap]
R (18)
pBAD18 oriColE1 [Ap]
R (32)
p112 pTRC99A::intI1, oriColE1 [Ap]
R (33)
p453 orip15A [Cm]
R (7)
p1187 pUC19::attCaadA7- catT4-VCR2 This study
p1266 pSU38i, orip15A [Km]
R This study
p1370 pSU38i::lacZ, orip15A [Km]
R This study
p1372 pSU38i::lacZ::attCaadA7-catT4t-VCR2,
orip15A [Km]
R
This study
p755 pSU38i::attI1, orip15A [Km]
R (7)
p1880 pSW23T::VCR2/1B, oriR6Kg [Cm]
R (7)
p2677 pSU38-ccdB-attI1, orip15A [Km]
R This study
p734 pBAD18::intI1, oriColE1 [Ap]
R This study
p4067 pBAD18::intI1_P109L, oriColE1 [Ap]
R This study
P4130 pBAD18::intI1_D161G, oriColE1 [Ap]
R This study
p4634 pET3a::HisInt [Ap]
R This study
p4635 pET3a::HisIntD161G [Ap]
R This study
p4636 pET3a::HisIntP109L [Ap]
R This study
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The intI1 mutants library was generated by mutagenic
PCR, using the ‘gene morph PCR mutagenesis’ Kit from
Stratagene. As the mutation frequency directly relies on
the DNA matrix quantity, we used three diﬀerent
conditions, in order to theoretically generate 1–10 muta-
tions per kilobase, according to the manufacturer’s
instructions. intI1 was ampliﬁed from p112 (Table 2)
with primers reverse and forward (Table 3), digested by
EcoRI and HindIII and cloned at the same sites
of pBAD18, leading to pBAD18::intI1
 . The library
products of the three reaction conditions were then
introduced in TG1(F
 ) cells by electroporation. This
gave a total of 10
5 independent clones.
Integrationassay
The integration assay derives from the in vivo recombina-
tion assay we previously developed (6). It uses conjugation
to deliver one of the recombination substrates into a
recipient cell expressing IntI1 under the control of the
PBAD promoter in the pBAD18 vector (Table 2) and
carrying the partner recombination substrate on a pSU38
plasmid derivative. The recombination sites provided by
conjugation were carried on pSW suicide vectors
(Table 2). Brieﬂy, the donor strain b2163 [dapA , pir+]
carries an RP4(IncPa) conjugation system integrated into
its chromosome and can sustain pSW replication through
the expression of a chromosomally integrated pir gene.
The recipient is o198 [dapA+, pir ] a B462 derivative
which contains the pSU38-ccdB-attI1 [Km
R] (Table 2)
and either pBAD18::intI1WT or the mutant population of
pBAD18::intI1
  (19). As pSW replication absolutely
requires the  protein, the number of recipients expressing
the pSW marker directly reﬂects the frequency of
cointegrate formation between the conjugated pSW
plasmid and the target replicon. Conjugation was per-
formed as previously described (6). The integration
activity using this assay was calculated as the ratio of
transconjugants expressing the pSW marker, Cm resistant
colonies, over the total number of recipient Ap and Km
resistant colonies.
Selection assayby enrichment
This assay is based on the repetition of cycles of selection
for intI1
  mutants active on a given substrate, in a
competitive set up. The selection is exerted on their overall
propensity to perform the attC attI integrative activity
in the recipient strain. One cycle consists of four steps
(Figure 1), in which all mutants are subjected to selection
all together. The two ﬁrst steps consist of the integration
assay after suicide conjugation in o198, as described
Figure 1. Schematic representation of the enrichment cycle of the conjugation–recombination assay. Brieﬂy, the intI1 mutant population (IntI1
 )i s
carried in a recipient strain also carrying a attI1 plasmid (pSU38i::attI1) and subjected to an en masse suicide conjugation with a suicide plasmid
injecting the attC bs (ppSW23T::Vcr2/1B) or its mutated derivatives. Inactive intI1 mutants are symbolized by red dotted arrows, intI1 mutants
showing a decreased activity are symbolized by purple dotted arrows, while intI1 WT or mutants with WT or increased activity are symbolized by
green dotted arrows, as depicted in the cartouche. The four diﬀerent steps of the cycles are described in the Materials and Methods section, they will
result in an enrichment of the intI1
  population in mutants showing and increased activity, compared to the WT protein, on a given substrate.
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mutant genes are expressed under the control of AraC
from pBAD18::intI1
 .I no198, the attI1 site is carried by a
pSU38 derivative, which constitutively expresses the F
toxin CcdB, pSU38-ccdB-attI1. This strain also carries the
gyrA462 mutation which confers resistance to CcdB (20).
In a third step, all the selected cointegrates carrying
recipient cells are gathered, and the whole plasmid
population extracted. The selected pBAD18::intI1
  popu-
lation is then puriﬁed from the cointegrates produced by
recombination between incoming pSW::attC and the
pSU38-ccdB-attI1 by both a digestion with BglII and
KpnI, which only cleave in the pSW and the pSU38, and
transformation in DH5a, which is naturally sensitive to
CcdB. This double process is essential to guarantee the
elimination of all cointegrates formed after recombination
and that the (19) transformants obtained contain only the
pBAB18::intI1
  as if a pSU38-ccdB derivative survived
the digestion step, it would kill the transformed DH5a.
The transformants are once again gathered, subjected to
a plasmid maxipreparation, which is used to transform the
CcdB resistant o198, generating a new recipient cell
population (step 4 in Figure 1), that is used for the
reiteration of step 1. The evolution of the library was
followed by sequencing of the pBAD18::intI1
  in 50
randomly chosen clones after every other cycle.
Deletion assay
The deletion assay is based on the integrase ability to
delete a synthetic cassette, catT4-attCVCR2, by mediating
recombination between the attCaadA7 and attCVCR2 sites.
The synthetic cassette disrupts a copy of the E. coli lacZ
gene carried on a pSU38 (pSU38i::lacZ::attCaadA7-
catT4-attCVCR2) and prevents the lacZ productive transla-
tion by introducing a stop codon in the reading frame,
111bp downstream of the ATG codon. IntI mediated
deletion of the cassette restores a single reading frame
allowing functional b-galactosidase synthesis. IntI1 WT
and mutants were expressed from the pBAD18::intI1
plasmid used in the enrichment assay. Recombinants were
screened on S-Gal/LB agar blend from Sigma. The
deletion frequency was measured by determining the
ratio of [Lac
+] colonies (black) to [Lac
 ] colonies
(white). The assay was performed in strain KS272, an
E. coli deleted of the lac operon (Table 1).
Protein purification
Bacterial strain BL21(DE3)plysS was transformed with
the pET-derived plasmids expressing His-IntI1WT, His-
IntI1P109L and His-IntI1D161G, respectively. The protein
puriﬁcation was carried out as described by Johansson
and collaborators (21), with the following minor mod-
iﬁcations. The colonies from each plate were harvested
and grown overnight in 25ml of LB containing Ap and
Cm. After overnight incubation the cells were harvested
by centrifugation and resuspended in 25ml of fresh media
and inoculated in 2500ml LB supplemented with the
appropriate antibiotics. At log phase the cells were put on
ice in a 48C cold room for  1h for cooling, then induced
with 0.8mM IPTG and incubated overnight at 168C.
Thecells wereharvested bycentrifugation andresuspended
in 1 HisTrap buﬀer (GE Healthcare) supplemented
by protease inhibitor cocktail tablets, 1 tablet/50ml,
(Roche), imidazole to a ﬁnal concentration of 10mM
(GE Healthcare) and 1/10 the volume of 1% Triton
X-100 (SIGMA). Cells were then disrupted by sonication
and the supernatant collected after centrifugation with
a Sorvall centrifuge (rotor SS-34) for 30min at
12000r.p.m. The puriﬁcation was carried out in the
cold room, over 1ml HisTrap FF crude columns
according to manufacturer’s recommendations (GE
Healthcare) using 200mM imidazole in the 1  HisTrap
wash buﬀer. The proteins were eluted with 1  HisTrap
buﬀer containing 800mM imidazole. The proteins were
estimated to  80% purity after electrophoresis and the
concentration determined using the Bradford assay (22)
with BSA as a standard.
Electromobility shiftassay
EMSA with ss DNA. The puriﬁed proteins were incu-
bated with DNA oligonucleotides corresponding to the
bottom strand of the attCVCR2 site and of the various
mutant sites (Table 3). In the synthetic oligonucleotides,
the sequence corresponding to the central loop of the
hairpin in the attCVCR2 site, shown not to inﬂuence
the recombination frequency by the wt IntI1 (Bouvier
et al., to be published), was removed. Each reaction
contained 50ng of sonicated salmon sperm DNA, 12mM
HEPES–NaOH pH 7.7, 12% glycerol, 4mM Tris–HCl pH
8.0, 60mM KCl, 1mM EDTA, 0.06mg/ml BSA, 1mM
DTT, 200mM imidazole, 5mM phosphate, 125mM
NaCl, 0.6pmol P
32 labeled probe and 1.5mM protein, in
a ﬁnal volume of 20ml. For each probe a negative control
reaction without protein was also performed. Samples
were incubated at 308C for 20min before loading
onto a precooled 5% native polyacrylamide gel (30%
Acrylamide/Bis Solution, 29:1 Bio-Rad), with 1  TBE as
buﬀer. Gels were run at 20mA with water as cooling until
the bromo-phenol blue (BPB) had reached  5cm.
Identical batch of labeled probes were used in the
experiments shown and gels were run on the same day.
The corresponding gels in Figures S3–S5 were performed
as above with 100ng of poly dI-dC as unspeciﬁc
competitor and ran until the BPB had reached  11cm
in the gels. The amount of DNA used and the protein
concentrations are indicated in the ﬁgure legend.
EMSA with attI1. attI1 was ampliﬁed by PCR from
plasmid pSU38::attI1 using primers forward and reverse
(Table 3), generating a 300bp fragment. Each reaction
contained 50ng poly dI-dC, 12mM HEPES–NaOH pH
7.7, 12% glycerol, 4mM Tris–HCl pH 8.0, 60mM KCl,
1mM EDTA, 0.06mg/ml BSA, 1mM DTT, 200mM
imidazole, 5mM phosphate, 125mM NaCl, 0.001pmol
P
32 labeled probe and the amount of protein indicated
in the Figure 5 legend, in a ﬁnal volume of 20ml. Gels were
run at 20mA with water as cooling and 0.5  TBE
as running buﬀer, for  4h.
The gels were dried prior to autoradiography and visual-
ized using a phosphor imager 445 SI (Molecular dynamics).
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version 4.0.0 (FUJI Photo Film Co. Ltd.), manually
deﬁning the lanes and using the automatic peak search
function. All other functions were at default values.
RESULTS
Development of anenrichment selection assay
IntI1 has a relaxed speciﬁcity, in the sense that it is able to
recombine sites that have not only remote sequence
similarities but also huge structural diﬀerences—the
attI1 site seems to be recognized under canonical ds
form whilst attC sites are recognized as ss secondary
structures. Moreover, the activity of IntI1 is low compared
to other Y-recombinases (6). In order to determine if a
correlation between speciﬁcity and activity could exist, in
particular, if a more active IntI1 protein would also be
more speciﬁc, we performed an extensive mutagenesis of
the protein, generating a large library of mutants
collectively designated as IntI1
 , and developed an
enrichment selection assay to ﬁnd more active mutants
of IntI1. In this assay, the mutants are selected on their
recombination activity for the attC integration at attI1.
The enrichment is done by the repetition of cycles,
including the selection step. In theory with such a strategy,
the most active IntI1
  are positively selected and
concentrated after each cycle. The assay is described in
detail in materials and methods and in Figure 1.
IntI1 mutantlibrary
The IntI1
  library was generated by error prone PCR. A
library of 10
5 clones was created, using three diﬀerent
mutagenesis conditions to theoretically generate 1–7
mutations per kilobase. Sequencing of 50 clones showed
that the library contained 88% mutants with 1–9 amino-
acid substitutions, nucleotide (nt) deletions and/or inser-
tions. In addition, mutations were found scattered over
the length of the intI1 gene (see Supplementary Figure S1).
Enrichment capacity
The enrichment capacity of the assay was tested by
competition between wild-type IntI1 (IntI1WT) and several
IntI1 mutants with diﬀerent relative activities. These
IntI1
  mutants were chosen among the 50 clones
sequenced after the ﬁrst mutagenesis round, described
above. The R280 catalytic residue mutant, IntI1R280S, was
inactive; whilst mutants IntI1L87V and IntI1R25H–R263H
were respectively 10- and 100-fold less active than IntI1WT
(data not shown). Competitions were achieved by mixing
1, 10, 50 or 90% of recipient strain containing IntI1WT
and respectively 99, 90, 50 or 10% of recipient strain
containing the diﬀerent IntI1
 , at the conjugation step of
the ﬁrst cycle. After each enrichment cycle, IntI1WT/IntI1
 
ratio was determined by PCR on the colonies obtained
after the recombination selection. The discrimination
between IntI1WT and IntI1
  was permitted by the addition
of a speciﬁc silent nucleotide sequence downstream of the
IntI1WT gene in pBAD18::intI1WT, allowing speciﬁc PCR
ampliﬁcation. One cycle of selection was suﬃcient to
completely eliminate the inactive IntI1R280S mutant,
irrespectively of the initial IntI1WT/IntI1R280S proportions
(Table S1). With the 100-fold less active IntI1R25H–R263H
mutant, we observed a massive proportion decrease after
the ﬁrst cycle and complete disappearance after the second
enrichment cycle (Table S1). In the case of the moderately
aﬀected IntI1L87V mutant (which retained 10% of the
IntI1WT activity), the IntI1WT proportion increased more
progressively (Table S1). In the control competition, when
two IntI1WT were mixed in 50:50 ratio, this ratio was
conserved for the two cycles (Table S1).
Selection formutants withahigher recombination activity
on awild-type attC site,attCVCR2
We pooled the 10
5 mutants and subjected them en masse
to the enrichment strategy using attCVCR2 (hereafter called
VCRWT). We followed the enrichment by sequencing 50
randomly chosen clones at diﬀerent cycles. As expected
from the elimination of both the inactive mutants and
those showing a reduced activity in comparison to
IntI1WT, the mutant proportion drastically decreased
from 88% to 21%, during the ﬁrst cycles of the
enrichment (Figure S2). Subsequently, the mutant propor-
tion increased until four mutants, IntI1D161E, IntI1D161V,
IntI1A4V–G322E and IntI1L287M became predominant.
These mutants altogether represented 70% of the mutants
in the library after 20 cycles (Figure S2).
Selection formutants withahigher recombination activity on
mutated attCVCR2 sites
The attC bs are folded as imperfect hairpins with
extrahelical structures. They all show an unpaired central
segment between the R and L boxes, and two to three
bases have no complement in the palindrome forming the
hairpin (Figure 2A). These extrahelical elements were
shown to be important for attC attC recombination
activity (2) and in vitro binding (2,21). The IntI1WT
recombination activity between attI1 and the VCRWT
mutants, VCRINV and VCRGTT, where these imperfec-
tions have been modiﬁed, is especially low. VCRINV is a
VCR derivative in which the sequences, which form the
unpaired central spacer located between the sequences
bound to the integrase monomers, are inverted
(Figure 2B). Structural data suggested that this unpaired
central spacer could direct the bending of the bs attC
tertiary structure, and as such play an important role for
recombination. In VCRGTT the three extrahelical bases,
G, T and T [G2000,T 1 00 and T1200, respectively, (2)] are
complemented (Figure 2B). While IntI1WT activity on
VCRWT is  10
 1, VCRINV and VCRGTT are recombined
with activities of 1.10 10
 4 and 3.76 10
 5, respectively
(Figure 3). The IntI1 mutant library was used in two
independent enrichment assays with these two VCR
mutated sites. In each assay, we found that a single
mutant represented more than 60% of the population
sequenced after six cycles. These mutants were IntI1P109L
in the library selected with VCRINV and IntI1D161G in the
library selected with VCRGTT.
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In vivo activities of mutants IntI1D161E and IntI1D161V. As
mutants at position 161 were also found in the selection on
the VCRGTT mutant site, we focused our investigations on
the two D161 mutants, IntI1D161E and IntI1D161V.Their
activities were tested in vivo, by integration and deletion
as described in materials and methods. To study the
speciﬁcity of the mutants, we chose to test recombination
using two diﬀerent attC sites: VCRWT, used for the
enrichment, and attCaadA7, which has a diﬀerent secondary
structure (Figure 2A). The deletion assay involves the
same attC sites, VCRWT and attCaadA7. IntI1D161E and
IntI1D161V were found to be more active than IntI1WT
in the integration assay with both attC sites, and also in
the deletion assay (Figure 3).
In vivo IntI1P109L activities. IntI1P109L recombines
VCRINV with an activity of 1.6   10
 2, 100-fold higher
than IntI1wt (Figure 3). This mutant is also more active
than IntI1wt, on VCRWT, attCaadA7 and attCorfA, in which
Figure 2. Proposed secondary structures of the attC sites bs studied in this work. Secondary structures were predicted using the MFOLD online
interface at the Pasteur Institute. The inverted repeats L0 and L00,R 0 and R00 are indicated with black arrows. The putative IntI1 binding domains, as
deﬁned by Bouvier et al. (2006), are marked with grey boxes. (A) Secondary structure of attCaadA7, VCR and attCofrA WT sites. (B) and (C)
Secondary structure of VCR mutants. Mutations are shown in red and in blue when they involve complementary mutations. The internal central
loop of the palindrome is shown by a black line mimicking the secondary structure predicted by MFOLD and shown in panel A. (D) VCRd, a VCR
derivative used in EMSA experiments, in which the central and imperfect part of the palindrome was replaced by GAA, numbering of the diﬀerent nt
according to our published work (2) is given in red above or below the cognate nt.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6481the unpaired central segment between the R and
L boxes has a diﬀerent organization (Figure 2A).
Moreover, when tested with VCRCOMP, a VCR mutant
in which the unpaired central segment is complemented to
eliminate the bulge (Figure 2B) as integration substrate,
its activity was found to be 4-fold higher than IntI1WT
(3.0   10
 2 and 7.62   10
 3, respectively, Figure 3).
Conversely, its deletion activity was found to be 6-fold
lower than the WT protein (Figure 3).
Another mutant in position P109, IntI1P109A, was
isolated in the randomly chosen clones sequenced at
diﬀerent stages during the enrichment of the library on
VCRWT. The activity of this mutant is closer to IntI1WT
activity on the tested substrates and inferior to the activity
of IntI1P109L (Figure 3).
Finally, we looked for the ability of IntI1P109L to restore
WT activity on the other VCR mutant substrate used in
this study, VCRGTT, where the mutations aﬀect the
extrahelical bases. Interestingly, we found that IntI1P109L
had a very low activity, similar to that of IntI1WT on this
substrate (1.6   10
 5 and 3.7   10
 5, respectively.).
In vivo IntI1D161G activities. IntI1D161G recombines
VCRGTT with an activity of 4.75   10
 3, 500-fold higher
than IntI1wt (Figure 3). The VCRwt integration frequency
catalysed by IntI1D161G is also higher than that of IntI1wt
on the same substrate (Figure 4). Furthermore, we tested
this mutant integration activity with diﬀerent VCR
mutants where: (i) only the extrahelical G is complemen-
ted, VCRG, (ii) the three extrahelical bases are deleted,
VCRiGTT and (iii) only the extrahelical G is deleted,
Figure 4. Gel retardation of bs VCRd derivatives by (A) His-IntI1WT
(B) His-IntI1P109L and (C) His-IntI1D161G. The substrate that the
respective mutant was selected on is underlined. 0.6pmol of each probe
and 1500nM of protein were used in each reaction. In the lanes marked
with –, no protein was added. Faster (F) and slower (S) complexes are
indicated by arrows.
Figure 3. Integration and deletion activities of IntI1WT and the IntI1
mutants, on diﬀerent recombination substrates. Integration assays are
between diﬀerent WT or mutant attC sites and the attI1 site, while the
deletion assays are between the attCaadA7 and the attCVCRWT sites.
Recombination frequencies (vertical axis of histogram) correspond to
the average of three independent trials. Error bars show standard
deviations. (A) Mutant IntI1P109L.( B) Comparison of IntI1P109L and
IntI1P109A mutants. (C) D161 Mutants.
6482 Nucleic Acids Research, 2007, Vol. 35, No. 19VCRiG (Figure 2C). In all cases, IntI1D161G was found to
be 10- to 100-fold more active than IntI1WT (Figure 3).
The recombination of these mutant substrates was further
tested with the D161 mutants selected on VCRWT,
IntI1D161E and IntI1D161V. The recombination activity of
these mutants on the mutated substrates was more similar
to that of IntI1wt than to IntI1D161G, although IntI1D161E
showed a 2- and 5-fold higher recombination rate
than IntI1wt on the VCRGTT and VCRiGTT substrates,
respectively (Figure 3).
Interestingly, as for IntI1P109L, the deletion activity of
IntI1D161G was found to be 10-fold lower than the WT
protein (Figure 3). The IntI1D161G activity on VCRINV
is as low as the IntI1wt activity on the same substrate
(6.8   10
 4 and 1.1   10
 4, respectively).
DNA Binding capacity of His-IntI1wt,His-IntI1P109Land
His-IntI1D161G
One possible explanation for the higher integration
activity of the mutants would be that they recognize the
DNA substrates better than IntI1wt. Hence, because of
having a greater binding capacity for the sites, they are
also able to mediate integration more eﬃciently.
Therefore, the binding capacity of IntI1wt, IntI1P109L
and IntI1D161G was investigated using EMSA. IntI1D161G
was chosen for puriﬁcation over IntI1D161E and
IntI1D161V, since it was the mutant in position D161 that
had the highest integration activity on all the assayed
substrates. To perform the EMSA, IntI1WT, IntI1P109L
and IntI1D161G were produced in His-tagged versions
and were puriﬁed by metal aﬃnity chromatography on
Ni-NTA.
EMSA with the VCR sites. The diﬀerent VCRs used in
the conjugation assays were tested in EMSA as well.
Single-stranded oligonucleotides of  90 bases, containing
a shorter version of the VCR (VCRd) were used as
substrate. In this substrate, the central part of the site that
corresponds to the imperfect matches of the palindrome,
namely the loop structure, was removed and substituted
with GAA (Figure 2D). This modiﬁcation has been shown
to have no eﬀect on the in vivo recombination frequency.
The recombination capacity of the corresponding VCRd
mutant substrates VCRdINV and VCRdGTT, was con-
ﬁrmed, using the conjugation assay with the His-tagged
IntI1wt, IntI1P109L and IntI1D161G proteins (data not
shown). At the same time, the His-tagged mutants were
shown to be recombinogenic. The basal T7 promoter leak
was suﬃcient to confer a recombination frequency of
1/100th of the frequency obtained in arabinose-induced
conditions from the pBAD::intI1. Furthermore, the
relative activity of the His derivatives were similar to
those of the non His-tagged proteins (data not shown).
This was expected as a large N-terminal extension such as
the MBP-tag had been previously shown to leave the
recombination activity of IntI1 unaﬀected (23).
His-IntI1WT, His-IntI1P109L and His-IntI1D161G were
assayed for binding with all the VCRd substrates. The
results from the EMSA experiments can be seen in
Figure 4 and in Figures S3–S5. In presence of the His-
IntI1, distinct bands corresponding to diﬀerent protein–
DNA complexes can be seen. The faster migrating
complex is always weak, if detectable. The slower
migrating complex is a double band that can be separated
with an increased migration time (Figure S3). The band
intensities on the gels in the supplementary ﬁgures were
quantiﬁed as described in materials and methods. The
results were used as a complement in the interpretation
of the gels (Figures S3–S5).
Interestingly, one can see with His-IntI1WT that there is
a rough correlation between binding to a given substrate
and in vivo recombination rates, i.e. those bound the most
poorly, being those that recombined at the lowest rate,
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Figure 5. Gel retardation of ds attI1 by His-IntI1WT, His-IntI1D161G and His-IntI1P109L (A) and its quantiﬁcation (B). (A) The amount of protein
used in the EMSA were respectively of 563nM, 750nM, 1125nM and 1500nM, for each His-IntI1 derivative. 0.001pmol of ds attI1 probe was used
in each reaction. (B) Fraction ( 100) of the labeled DNA substrate bound by the His-IntI1 derivative in complexes I or II/labeled (bound+free)
DNA, detected by automatic peak search of Image Gauge.
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with VCRdINV, which if bound only slightly less than
VCRdWT in vitro, is recombined with a 1000-fold lower
frequency.
His-IntI1P109L and His-IntI1D161G both bind the
VCRdwt with a better eﬃciency than His-IntI1WT
(Figure 4 and Figure S3). All versions of the His-IntI1
proteins bind to the VCRdG and VCRdiG substrates.
Nevertheless, with these substrates, the slower migrating
complex only weakly observed with the wt protein, is more
prominent with the His-IntI1P109L and His-IntI1D161G
mutants (Figure 4). In fact, the His-IntI1wt binding to the
VCRdG and VCRdiG substrates is too low to be detected
by Image Gauge (data not shown). The binding to the two
substrates that lack the extrahelical nt in the L box stem,
VCRdGTT and VCRdiGTT is when distinguishable very
poor for all three proteins (Figure S5).
For the substrates VCRdCOMP and VCRdINV, both the
mutant proteins recognize these substrates slightly better
than His-IntI1WT (Figure 4 and Figure S4). All proteins
bind VCRdINV slightly better than VCRdCOMP, where
the largest diﬀerence is for His-IntI1wt (Figure 4).
In summary, the EMSA experiments show that both the
mutants bind slightly better than the WT protein to
the substrates VCRdwt, VCRdINV, VCRdCOMP, VCRdG
and VCRdiG; with, in addition, an increment in the
slower complex formation for both mutants with the last
two substrates.
EMSA with the attI1 site. The common DNA substrate
in the diﬀerent enrichment experiments was ds attI1.
His-IntI1WT, His-IntI1D161G and His-IntI1P109L were
assayed for their binding to the attI1 site (Figure 5).
IntI1WT has been shown to have less aﬃnity for ds attI1
site than for bs attC sites (6). This was true also for the
His-IntI1WT and the mutants. While the protein to DNA
ratio in the experiments with the attC bs is 50:1,
the protein to DNA ratio for the attI1 shifts is almost
600 times higher. However, the EMSA experiments show
that both mutant proteins bind attI1 diﬀerently than
His-IntI1WT. Two distinct complexes can be seen with
the WT protein, complex I and complex II (Figure 5).
With the two mutant proteins, complex II is the most
distinct (Figure 5). The amount of shifted DNA is slightly
(up to 1.5 ) higher for both mutants compared to
His-IntI1WT.
DISCUSSION
IntI1 is considered as the paradigm of the Y-recombinases
subfamily of the integron integrases. The integron
integrases have the rare ability to recombine ss and ds
DNA, the bs attC and attI, respectively. It is extremely
interesting to investigate what in its structure allows such
diﬀerent behaviors. Unfortunately, IntI1 has proven
diﬃcult to crystallize and its structural studies have been
limited to a few directed mutagenesis studies (4,23).
We recently reported the 3D structure of the V. cholerae
superintegron integrase VchIntIA (2), which shares 45%
identity and 65% similarity with IntI1 (24), and have
been shown to have similar recombination properties,
especially in terms of their attC substrate spectrum (7).
The crystal structure of VchIntIA in complex with bs
attC sites of the VCR type, which corresponds to the
cassette deletion reaction, has provided several answers to
the questions raised by the dual speciﬁcity of IntI, but
many aspects of the mechanism are still elusive. In this
study, we chose to look closer at the relationship between
the structure and the properties of IntI1, by selecting
after an extensive mutagenesis, mutants of the protein
more active in the attI1   attC integration reaction on
either WT or mutated attC substrates. In order to
facilitate the analysis of the results, we choose to perform
the selection using a VCR attC site, or its mutated
derivatives. Indeed, as the available 3D structure corre-
sponds to complex of VchIntIA with this speciﬁc attC site,
this option should limit structural speculations to the
parallel modeling of IntI1 structure based on the one of
VchIntIA rather than to any diﬀerence in the structure of
the attC.
The hypermutagenic PCR method we used generated a
library of 10
5 independent clones, showing a broad
spectrum of mutations and a large proportion of mutants.
As it seemed unreasonable to analyse their recombination
properties one by one, we decided to adopt an enrichment-
by-cycling strategy and perform an en masse selection,
analogous to the in vitro approaches (25,26).
We postulated that for plasmids expressing a protein
variant, producing an increment in the eﬃciency of
attC attI1 recombination would ultimately generate a
larger number of progeny carrying a cointegrate in our
suicide conjugation assay. Based on the initial competition
trials where IntI1 variants with 10% or 1% residual
activity were eﬃciently eliminated in competition with
IntI1 WT (Table S1), we applied the cycling of selective
steps protocol to the library. The principle of the
enrichment assay is based on the controlled repetition of
steps and on the advantageous possibility of changing or
modifying each partner of the recombination reaction
independently (IntI, attI or attC) (Figure 1). The system is
highly eﬀective since we observed that inactive mutants
were eliminated after the ﬁrst cycle, whilst others either
decreased or augmented proportionally to the number
of cycles, depending on their relative lower or higher
recombination activity.
Although the library we constructed had in theory a
large redundancy for a 337 amino acid protein, the low
probability of multiple mutations in the same codon
favored dispersed amino acid changes involving a single
nucleotide switch. The analysis of 50 randomly chosen
clones by sequencing, showed that our library contained
many multiple mutants with 2–9 substitutions (Figure S1).
With a size of 10
5 independent clones, our library covered
a certain set of these possible multiple mutants, but still a
minor fraction of all possible ones.
Initially, using WT attI1 and a WT attC site of the VCR
family, four mutants became predominant after 20 cycles.
Two of them, IntI1D161E and IntI1D161V, were shown to be
slightly more eﬃcient than IntI1wt in integration via
attC   attI1 recombination using two structurally
diﬀerent WT attC sites, VCRWT and attCaadA7.
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attC recombination.
Subsequently, two VCR mutant sites, VCRGTT and
VCRINV, both altered in the extrahelical structures of
the bs attC site (Figure 2B and C) were used. This resulted
in the selection of IntI1D161G and IntI1P109L, respectively.
IntI1P109L, was more active for integration than IntI1WT
on the diﬀerent WT attC substrates, but showed a
decrease in deletion eﬃciency. An alanine at this position
has no eﬀect on the protein activity (Figure 3).
Interestingly, the residue found at the homologous
position to P109 is a leucine in VchIntIA (Figure 6B)
and several other Vibrio IntIA (data not shown).
IntI1D161G, is more active for integration than IntI1WT
with all the WT and VCRGTT related substrates, while its
deletion activity through attC attC recombination is
about 10-fold lower than that of IntI1wt. This substitution
by a glycine residue brings the integration eﬃciency with
the VCR (mutagenized in its extrahelical bases) to a
level similar to that of IntI1WT on VCRWT. Among the
diﬀerent amino acid substitutions identiﬁed at position
161, glycine is the only one having such a phenotype
(Figure 3).
It is surprising that these mutants were not selected on
VCRWT as we started the selection cycling from the same
library. During the 20 cycles of the enrichment assay on
VCRWT, we recloned the entire library into a new vector
every third cycle in order to avoid mutations accumulation
in the plasmid carrying intI1
  that could confer an indirect
higher recombination frequency; i.e. mutations in the
inducible promoter, its activator or in the replication
origin of the plasmid. Despite our eﬀorts to avoid it, it is
possible that in these manipulations, some mutants might
have been lost.
The low number of mutants with a higher activity
we isolated with this method, the small number of
positions touched by these mutations and the relative
small increment in activity obtained (2- to 3-fold), suggests
that the activity of IntI1 is not limited by the structure
of the integrase. Indeed, we found only two positions
(109 and 161) where substitutions slightly increase IntI1
activity. The two other mutants selected in the VCRWT
enrichment, L287M and A4V-G322E, show an even
smaller increment (data not shown). In addition, none of
these mutants showed a narrowing of the attC site
recognition spectrum, as their recombination increment
was not limited to the VCR site used for the selection, but
was also eﬀective with the shorter and unrelated attCaadA7
site. This suggests that the IntI1 activity is not limited by
a necessary structure/function compromise to recognize
the many structurally diﬀerent attC sites. The IntI1
structure is also constrained by the various interactions
in which the protein is involved: (i) the interaction with ss
substrates, (ii) the interaction with the ds substrate,
(iii) the monomer folding and (iv) the interactions between
the protein subunits. It is probable that the natural
availability, or the production, of the ss form of the attC
substrates inside a cell is the major limitation of the
recombination, rather than the catalytic properties of the
integrase itself.
DNA binding aptitude ofthe different IntI1 mutants
The results of the diﬀerent EMSA experiments clearly
show that one cannot reduce the eﬀect of the selected
protein mutations to a site recognition improvement.
Indeed, both the IntI1D161G and IntI1P109L mutants bound
the bs attC and ds attI1substrates only slightly better than
IntI1wt (Figure 4 and Figure S3), hinting that the
recognition of both substrates through speciﬁc binding is
secondary in terms of selective forces in the assay, even if
these increments could account for some of the observed
increase in recombination frequency.
As mentioned in the results, a site such as VCRINV
which is recombined with a 1000-fold lower frequency
than the VCRWT, is eﬃciently bound in vitro and produce
the same complexes as the WT site. This suggests that
in this case, the reaction is aﬀected at a later stage, either
at the bs attC   ds attI synapse assembly or the cleavage
activation. Moreover, if there is in general a rough
correlation between the binding to a given substrate and
its in vivo recombination rates, i.e. those bound the most
poorly, being those recombined at lowest rate, as for
example VCRdGTT, this is not the case with the IntI1
mutants selected. Indeed, the very weak binding to the
VCRdGTT and the VCRdiGTT observed for the WT
protein is conserved with both mutants, even if one of
these, IntI1D161G which was selected on the ﬁrst site,
recombine them at 140-fold and 20-fold higher rates,
respectively.
Another case of diﬀerences in the recombination of a
given attC substrate that do not directly correlate with the
binding, is that of IntI1D161G which binds VCRINV better
than VCRGTT while its in vivo integration activity is 8-fold
higher with the latter (Figure 4, Figures S3 and S5).
These discrepancies conﬁrm that DNA binding in itself
is not the unique determinant for an eﬃcient recombina-
tion, and suggest that the selection with these speciﬁc
mutants sites mainly acts on the aptitude to form a
proﬁcient synaptic complex, gathering the four subunits
and the two diﬀerent substrates, the ss attC and ds attI,
and/or for the cleavage activation.
3Dmodeling of theIntI1 mutants
To get a better understanding of the mutants properties,
we made a 3D model of IntI1wt, based on the crystal
structure of VchIntIA in complex with VCRbs (2). IntI1
and VchIntIA share 45% identity and 65% similarity. The
model of the IntI1 molecule was built for both the cleaving
and non-cleaving subunits. Regions that were not visible
in electron density in the VchIntIA structure were not
considered. The model shows the spatial positioning of the
residues of IntI1 relative to their alignment with
VchIntIA. For the sake of clarity, in the following part
of the discussion, IntI1 amino acids numbering are always
followed by a parenthesis giving the corresponding residue
and its numbering in VchIntIA. A schematic picture of the
attC attI1 synaptic complex and a secondary structure
alignment between IntI1 and VchIntI1A are presented in
Figure 6.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6485Figure 6. (A) A schematic picture of the IntI1 synapse with attC attI1. Subunits B and C are striped since the positioning of these molecules cannot
be predicted from the crystal structure of the VchIntIA, made from an attC attC recombination complex. (B) Alignment of the protein sequences
from IntI1 and VchIntA. The residues carried by the mutants selected by the enrichment assay are in frame. Those selected on the mutated attCVCR
substrates are in bold, red and with a red frame. The secondary structure of VchIntIA with the b-strands (arrows) and the a-helices (cylinders) is
presented below the sequence alignment.
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helixes (D and F, see Figure 6) which functions as a hinge
between the N-terminus and the C-terminus of the protein
(Figure 7). A change from a sterically constrained proline
(and helix breaker, see below) to a leucine, would give
a higher ﬂexibility to this linker region, which could help
to accommodate the distortion of the substrate caused by
the exchange of the unpaired central segment, and lead to
a higher recombination frequency with this speciﬁc
substrate. A correlate to this observation is the absence
of prolines in this segment of the primary structure in the
case of Cre. Indeed, the equivalent region in Cre carries
a-helix E, which is involved in extensive inter subunit
contacts with a-helix A for binding DNA in cis. The
requirement for structured secondary elements in this
region would favor ds type DNA binding, with 6–8bp
spacing. In the integron integrases (IntI1, VchIntIa) which
bind non-canonical ss DNA with a bulge, the presence of
two prolines (P107, P109) and one proline (P86) respec-
tively, maintains this region in an unstructured state thus
providing the necessary ﬂexibility required for recognition
and binding of such substrates (Figure 7B). The observa-
tion that the C-terminal part of the linker, which contains
this residue, is in close proximity to the DNA of the
central unpaired segment (T2600–T2800 and facing nt
G160–C180, see ﬁgure 2D), strengthen the hypothesis that
the higher ﬂexibility in this region could enhance the
formation of a productive synapse in the case of a
modiﬁed central segment, be it inverted or fully annealed.
It is noticeable that the P109L substitution does not aﬀect
the recombination of the substrates mutated in the
extrahelical bases T1200, T1600 and G2000, which are located
in remote regions of the substrate. On the other hand,
the P109L substitution has a negative eﬀect on the
attCWT attCWT recombination, as attested by the
6-fold decrease of the deletion frequency (Figure 3).
Interestingly, however, this also suggests that the higher
ﬂexibility introduced in the P109L protein is prejudicial
for the synaptic complex stabilization formed in the bs
attC bs attC reaction.
Position 161. The integron integrases alignment shows
that the amino acid residue found at this position is in
most cases an aspartate or a glutamate. In both IntI1 and
VchIntIA, it is an aspartate, D161 and D150, respectively.
The 3D model reveals that it is situated in a key area at the
interface between the A and D (and the C and B)
molecules in the protein–DNA synapse (Figure 7C).
Indeed, across the D161 residue of subunit A [D161A]
two residues are found within distance for hydrogen
bonding or ionic interactions, protruding on the D
molecule, K272D (K262) and E121D (E110). K272D
(K262) is preceded by the helix J that is in contact with
the major groove (Figure 7C). Another attribute of this
area is its proximity to the entry point of the D subunit
C-terminal helix N (Figure 7C), which has a stabilizing
function on the synaptic complex, and postulated to
participate in the regulation of the cleavage step in the
case of the Cre recombinase (27). D161 is located in
the loop between the b-sheets 1 and 2. b-sheet 2 contains
one of the two residues, R168 (W157), which interact with
Figure 7. Model of IntI1 based on VchIntIa-VCRbs x-ray structure (2).
(A) The monomer corresponding to subunit A is shown, positioned
relative to the VCRbs DNA. The position of P109 is shown in green, in
the linker region spanning the N-to-C terminal domains of the integron
integrase. (B) Close up of the P109L mutant in the linker region of the
intI1 model. P109 is located in a key position to inﬂuence the ﬂexibility
of the N-ter to C-ter domain hinge. When compared to Cre, this region
harbors an a-helix (a-E), thus much more structured that in the
integron integrases. It is also in the viscinity of the bulge due to the
3bp mismatch of the DNA substrate. (C) Close up of the D161 mutant
in the intI1 model. The region is located at the interface between trans-
bound monomers. Interfacial contacts between D161A and E121D or
K272D help to maintain these molecules closer, hence reinforcing the
synapse. This region is the entry point of the domain swapped a-N
helix between the D and A subunits.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6487the extrahelical base G2000 (2) and stabilize the synaptic
complex. It is remarkable that three of the selected
mutants carry a mutation of the D161 residue. The
substitution of D161 by a glycine, does not lead to the
same phenotype as its substitution by a valine or a
glutamate (Figure 3). Glycine has no lateral chain and can
radically change the structure of the loop between b-sheets
1 and 2, while the lateral chain size of a valine or a
glutamate should conserve the global loop structure.
These results suggest that this loop, and D161 in
particular, are very important for the inter subunit
protein/protein interaction. Mutations made of the next
amino acid in this loop H162, further illustrates the
importance of the loop, where substitutions to a E, G or
A, decrease the recombination frequency about 5-fold,
and to a K, by 100-fold (data not shown). However, no
gain-of-function mutations were found at this position.
Astructural trade-offto guarantyproductive recombination
As illustrated by Grindley and colleagues in their review
(28), the outcome of the recombination is determined by
the conformation of the DNA in the initial synaptic
complex. The initial recombinase-bound duplex bending
would decide which strand would be cleaved ﬁrst. bs attC
site secondary structure does not oﬀer the two alternate
bending possibilities. The unpaired central segment
imposes a structural bending, visible in the 3D structure
of the crystallized complex, which shows an elbow in the
bs attC site due to the unpaired central segment (2).
Moreover, the interactions in cis and in trans with the
extrahelical bases do not allow HJ isomerization (2), such
that only one conformation is compatible with recombi-
nation. Hence, only one strand is cleaved and this is
always the same strand. Therefore, one can consider that
the unpaired central segment and the extrahelical bases
directly or indirectly determine the outcome of recombi-
nation. This is supported by our results, as modiﬁcations
of the central segment structure or mutations of the
extrahelical bases directly aﬀect the IntI1WT recombina-
tion activity. The IntI1D161G and IntI1P109L mutants
restore recombination activity on the mutated substrate
used for their respective selection. It is interesting to note
that both show the same in vivo properties—a higher
activity in the attI attC reaction, and a lower activity for
the attC attC reaction—while in vitro, they both show a
slight increment in their aﬃnity for both the bs attC and
the ds attI. According to structural modeling, both
mutations would lead to an increment in the relative
ﬂexibility of the integrase (intra, and inter subunit), and
modify the protein/protein or the protein/DNA interac-
tions involved in the integration reaction synapse. These
ultimately lead to an increase in the recombination
frequencies. On the other hand, the correlated relative
decrease in the attC attC recombination frequency
suggests that an increase in protein ﬂexibility is deleterious
for the assembly or the stability of synaptic complexes
exclusively involving the folded bs attC. An explanation
could be that complex formation, which involves a ﬂexible
bs attC and a stiﬀer ds attI, is facilitated with an IntI1
mutant having an improved ﬂexibility, whilst in the bs
attC   bs attC complexes, both substrates are ﬂexible and
the resulting synapse become less stable than in the bs
attC ds attI reaction. The extrahelical G is involved in
the stability of the synapse, via its interaction in trans with
the active subunits (2). This particular conformation
allows the correct protein/protein interaction between
the subunits bound to the same type of substrate. A higher
ﬂexibility in IntI1 structure would allow for better attI1
binding but would no longer provide this in trans
interaction that stabilizes the synapse. In the integration
process, the loss of ﬂexibility would be compensated for by
the gain of attI binding, while in the deletion reaction, the
loss of ﬂexibility would aﬀect both IntI1 dimer-attC
complexes. One can imagine that in this case, the gain in
binding capacity we observe in vitro is not suﬃcient to
compensate for the ﬂexibility loss.
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